Rejection, Transplant Completed Phase 3 Trials for Basiliximab (DB00074)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00251004Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant RecipientsTreatment